Company / Operating Margin
FENNEC PHARMACEUTICALS INC. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
5.4%
FY2025
5-year range
-10520.6% / 5.4%
FY2021-FY2025
Trend
+109.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has increased for 3 consecutive years, from -10520.6% in FY2021 to 5.4% in FY2025.
Based on SEC 10-K filings.
5.4% in FY2025.
Improved from -1471.6% to 5.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- FENNEC PHARMACEUTICALS INC.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 109.0% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.4% | +109.0% |
| FY2024 | -60.1% | +95.9% |
| FY2023 | -1471.6% | +86.0% |
| FY2021 | -10520.6% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026